Jim Cramer: No Room for Cynicism, JNJ's New Depression Drug Is Lifesaving

The approval of esketamine, known as Spravato, for use against severe depression is special -- it is saving lives.

What to Expect from GE's Health Care Conference on Thursday

One of General Electric's biggest liabilities will be outlined on Thursday.

Intuitive Surgical Could Trade Sideways Before Hitting All-Time Highs

Traders could go long on ISRG here, or wait to buy strength.

Larry Culp's Cash Flow Comments Continue to Crush GE Stock

General Electric's CEO isn't inspiring much confidence.

Jim Cramer: For CVS the Action Is Bad, the Stock Is Cheap

This is one where many shareholders can no longer take the pain and will sell at all costs.

Fighting the Good Fight vs. a System That Values Speed Over Price: Market Recon

If we didn't know where the algorithms that now control the point of sale were lined up before Monday, we sure know now.

A Technical Strategy for Tandem Diabetes Care

Are we late to the game with the stock up so much?

5 Attractive Ways to Invest in Oncology

Experts offer their top stock ideas in oncology detection and treatment.

UnitedHealth Group Could Fall Further - Defense Coming Onto the Field

Let's see what we can glean from the charts and indicators.

CVS' Massive M&A Moves Spark Skepticism on the Stock

CVS' spending spree has developed a deep debt issue for the company.